PSYENCE BIOMEDICAL LTD Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents
PSYENCE BIOMEDICAL LTD (PBM) reported Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents of -$11.23 thousand for the 6-month period ending 2025-09-30, per its 6-K filed 2025-11-20.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents · last filed 2025-11-20
| Period end | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 6 month | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 12 month |
|---|---|---|
| 2025-09-30 | -$11.23K 6-K · filed 2025-11-20 | |
| 2025-03-31 | -$6.35K 20-F · filed 2025-06-25 |